Jan R. Holmgren
Goeteborg, O 42674, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Heterologous prime-boost immunization combining parenteral and mucosal routes with different adjuvants mounts long-lived CD4+ T cell responses in lungs.
Journal: Frontiers in immunology
Published: March 25, 2025
Potential for a Combined Oral Inactivated Whole-Cell Vaccine Against ETEC and Shigella: Preclinical Studies Supporting Feasibility.
Journal: Vaccines
Published: March 20, 2025
Safety, Tolerability, and Immunogenicity of the InvaplexAR-DetoxShigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial.
Journal: Vaccines
Published: November 15, 2024
Protection by natural cholera against later episodes of cholera over 10 years of follow-up in Matlab, Bangladesh: a retrospective cohort study.
Journal: The Lancet. Microbe
Published: October 24, 2023
Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa.
Journal: Journal of travel medicine
Published: January 05, 2023
S100A4 exerts robust mucosal adjuvant activity for co-administered antigens in mice.
Journal: Mucosal immunology
Published: February 15, 2022
Evaluating improved inactivated oral cholera vaccines for use in ending endemic cholera by 2030: opportunities and challenges.
Journal: The Lancet. Infectious diseases
Published: February 03, 2022
Last Updated: 09/26/2026